» Articles » PMID: 8466282

Adrenal Androgen Abnormalities in Women with Late Onset and Persistent Acne

Overview
Specialty Dermatology
Date 1993 Jan 1
PMID 8466282
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Androgens are an essential prerequisite for the development of acne. The present study was undertaken to characterize the androgen status of women with late onset and persistent acne only and, using the dexamethasone (dex) suppression test, to identify the source(s) of the androgen excess. We measured serum levels of total testosterone (T), free testosterone (FT), androstenedione (delta 4A), dihydrotestosterone (DHT), dehydroepiandrosterone sulphate (DHEA-S) and sex hormone binding globulin (SHBG) in 34 healthy control subjects, in 34 women with mild acne and in 29 women with moderate or severe acne. Serum FT, DHT and DHEA-S levels in patients of both acne groups were significantly higher than those in the control subjects. The other hormone levels showed no significant differences between patients and control subjects, and there were no significant differences between the two acne groups in any of the androgen levels. In order to evaluate the ovarian and adrenal contributions to serum androgens in the acne patients, the serum levels of delta 4A, T, DHT and DHEA-S were measured prior to and following 2 weeks of dex therapy. Following the dex test, the DHT and T of adrenal origin were significantly higher in the acne patients than in the control subjects. These results suggest that, in acne patients, hyperandrogenaemia is likely to develop as a result of adrenal androgen excess. In addition, since abnormally high androgen levels are frequently seen in late onset and persist acne, it seems that this condition is likely to be a sign of hyperandrogenism.

Citing Articles

Adult acne versus adolescent acne: a narrative review with a focus on epidemiology to treatment.

Kutlu O, Karadag A, Wollina U An Bras Dermatol. 2022; 98(1):75-83.

PMID: 36253244 PMC: 9837660. DOI: 10.1016/j.abd.2022.01.006.


FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial.

Poinas A, Lemoigne M, Le Naour S, Nguyen J, Schirr-Bonnans S, Riche V Trials. 2020; 21(1):571.

PMID: 32586344 PMC: 7318446. DOI: 10.1186/s13063-020-04432-w.


[Acne tarda. Acne in adults].

Jansen T, Janssen O, Plewig G Hautarzt. 2013; 64(4):241-51.

PMID: 23576169 DOI: 10.1007/s00105-012-2458-0.

References
1.
Lucky A, Rosenfield R, McGuire J, Rudy S, Helke J . Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and/or hirsutism: adrenal enzyme defects and exaggerated adrenarche. J Clin Endocrinol Metab. 1986; 62(5):840-8. DOI: 10.1210/jcem-62-5-840. View

2.
ABRAHAM G, Maroulis G, Buster J, Chang R, Marshall J . Effect of dexamethasone on serum cortisol and androgen levels in hirsute patients. Obstet Gynecol. 1976; 47(4):395-402. View

3.
Vexiau P, Husson C, Chivot M, Brerault J, Fiet J, Julien R . Androgen excess in women with acne alone compared with women with acne and/or hirsutism. J Invest Dermatol. 1990; 94(3):279-83. DOI: 10.1111/1523-1747.ep12874121. View

4.
Darley C, Moore J, Besser G, MUNRO D, Edwards C, Rees L . Androgen status in women with late onset or persistent acne vulgaris. Clin Exp Dermatol. 1984; 9(1):28-35. DOI: 10.1111/j.1365-2230.1984.tb00751.x. View

5.
Sonoda T, Itami S, Kurata S, Takayasu S . Influences of gonadal and adrenal androgens on the side glands of Suncus murinus. Endocrinol Jpn. 1991; 38(3):253-8. DOI: 10.1507/endocrj1954.38.253. View